Tag: Bioinformatics
Search News
New spinout launches to advance early pancreatic cancer detection
29th October 2025
Queen Mary University of London has launched a new company, Procyon Diagnostics, to provide pioneering early cancer detection tests. The company’s first test, PancRISK, offers new hope for detecting pancreatic cancer earlier, building on over 15 years of research by Professor Tatjana Crnogorac-Jurcevic at Queen Mary’s Barts Cancer Institute (BCI), funded by the Pancreatic Cancer Research Fund.
Read more
Pancreatic Cancer Research Fund Tissue Bank achieves landmark international accreditation
19th August 2025
The Pancreatic Cancer Research Fund Tissue Bank (PCRFTB) has become the first in England to receive ISO 20387:2018 accreditation, an international standard that recognises excellence in biobanking.
Read more
Beyond ‘one size fits all’: Study reveals ethnic differences in breast cancer development and outcomes, demanding tailored care approaches
20th May 2025
Women of African or South Asian genetic ancestry tend to develop breast cancer and die at a younger age than women of European ancestry, according to new research by Barts Cancer Institute, Queen Mary University of London. The study, which looked at clinical and genetic data from over 7,000 women with breast cancer, also found important genetic differences in these women’s cancers that could impact their diagnosis and treatment.
Read more
International study reveals four distinct types of oesophageal cancer
23rd October 2024
New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.
Read more
Dr Mirjana Efremova awarded £1m Cancer Research UK grant to decode bowel cancer’s plastic nature
14th December 2023
Congratulations to Dr Mirjana Efremova who has been awarded a £1m grant to use cutting-edge computational tools to study how bowel cancer adapts.
Read more
New tool predicts risk of skin cancer spread more accurately than human inspection
12th October 2023
These results could aid the treatment of individuals most at risk of aggressive skin cancer.
Read more